Related Experiment Video
Updated: Jun 3, 2026

Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions
Published on: August 2, 2018
Hypoxia-induced β-catenin downregulation involves p53-dependent activation of Siah-1
Dapeng Wang1, Yongxing Wang, Tao Kong
1Institute of Radiation Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
Abstract:
Solid tumors contain extensive hypoxic areas and it is of considerable importance to decipher the potential role of hypoxia in signaling pathway regulation. In the present study, we examined the impact of hypoxia on β-catenin status and the mechanisms involved. Hypoxia significantly decreased β-catenin protein, but had no effect on glycogen synthase kinase (GSK)-3β or adenomatous polyposis coli (APC) levels. However, hypoxia-induced β-catenin downregulation seemed to require APC but not GSK-3β. Further investigation revealed that hypoxia significantly upregulated Siah-1, the human homolog of Drosophila seven in absentia. In addition, hypoxia augmented the interaction between β-catenin and SIP and Skp1. Silencing of Siah-1, as well as the use of a dominant negative Siah-1 mutant, attenuated these responses to hypoxia and rescued β-catenin transactivation. The Siah-1-mediated degradation of β-catenin during hypoxia may involve p53, but not hypoxia-inducible factor-1, activation. Together, the results suggest that hypoxia downregulates β-catenin by increasing Siah-1 expression in a p53-dependent manner.
Insights
Hypoxia, a condition in solid tumors, reduces beta-catenin protein levels by increasing Siah-1 expression. This process, dependent on p53, involves beta-catenin degradation and impacts tumor signaling pathways.
Area of Science:
- Molecular biology
- Cancer research
- Cellular signaling
Background:
- Solid tumors frequently exhibit hypoxic regions, necessitating an understanding of hypoxia's role in cellular signaling.
- Beta-catenin is a key protein in various signaling pathways, and its regulation is crucial in cancer.
Purpose of the Study:
- To investigate the impact of hypoxia on beta-catenin levels and elucidate the underlying molecular mechanisms.
- To identify the specific proteins and pathways involved in hypoxia-mediated beta-catenin regulation.
Main Methods:
- Western blotting to assess protein levels of beta-catenin, GSK-3β, and APC under hypoxic conditions.
- RNA interference and dominant-negative mutants to study the role of Siah-1.
- Co-immunoprecipitation to analyze protein-protein interactions between beta-catenin, SIP, and Skp1.
- Assessment of p53 and hypoxia-inducible factor-1 (HIF-1) activation.
Main Results:
- Hypoxia significantly decreased beta-catenin protein levels without affecting GSK-3β or APC protein levels.
- Hypoxia upregulated Siah-1 expression and enhanced the interaction between beta-catenin, SIP, and Skp1.
- Silencing Siah-1 or using a dominant-negative Siah-1 mutant reversed hypoxia-induced beta-catenin downregulation and restored transactivation.
- Siah-1-mediated beta-catenin degradation during hypoxia was dependent on p53 activation but not HIF-1.
Conclusions:
- Hypoxia downregulates beta-catenin in solid tumors through a mechanism involving increased Siah-1 expression.
- The Siah-1-mediated degradation of beta-catenin is dependent on p53 activation.
- These findings reveal a novel regulatory pathway linking hypoxia, Siah-1, and beta-catenin in cancer cells.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Canonical Wnt Signaling Pathway
Cell Specific Gene Expression
The JAK-STAT Signaling Pathway
Hedgehog Signaling Pathway
Abnormal Proliferation

